Novartis Acquires U.S. Cancer Specialist CoStim

19.02.2014 - Swiss pharmaceuticals giant Novartis has announced plans to acquire U.S. biotech firm CoStim. The privately owned cancer therapy specialist based at Cambridge, Massachusetts...